Funded Research Agreement – Life Sciences

Our client, a biotech start-up company focused on the rapid discovery of new molecular targets and the development of monoclonal antibodies, asked MillCrest Law to assist it with the negotiation and documentation of a funded research agreement with an Israeli biotech company. Pursuant to the agreement, our client is providing research and development services in support of its collaboration with the Israeli company in the development and commercialization of certain monoclonal antibodies and the creation of a new pipeline of antibody drugs for certain specified diseases.

At MillCrest Law, our goal is to grow our business with yours.

Comments are closed.